Browsing: OncoC4
Md., Nov. 2, 2026 /PRNewswire/ — OncoC4, Inc., a late clinical-stage biopharmaceutical company developing novel medicines for cancer and immunological diseases, today announced the appointment of Dr. Dan Janiak as Chief Business Officer